Case Reports in Clinical Medicine

Volume 9, Issue 6 (June 2020)

ISSN Print: 2325-7075   ISSN Online: 2325-7083

Google-based Impact Factor: 0.2  Citations  

Successful Management of Wound Dehiscence after Total Knee Arthroplasty by Topically Using Recombinant Basic Fibroblast Growth Factor

HTML  XML Download Download as PDF (Size: 565KB)  PP. 154-157  
DOI: 10.4236/crcm.2020.96022    547 Downloads   2,800 Views  
Author(s)

ABSTRACT

Wound complications are estimated to be affected in about 9% of TKA patients, which may increase the risk of deep periprosthetic infection and results in re-operation, joint fusion, or amputation. Here we have reported a female patient who suffered wound rupture due to early post-operation mobilization and weight-bearing. The wound dehiscence was successfully managed by applying recombinant basic fibroblast growth factor-2 and anti-infective treatment without removing prosthetic joint.

Share and Cite:

Zhang, J. and Lin, Z. (2020) Successful Management of Wound Dehiscence after Total Knee Arthroplasty by Topically Using Recombinant Basic Fibroblast Growth Factor. Case Reports in Clinical Medicine, 9, 154-157. doi: 10.4236/crcm.2020.96022.

Cited by

No relevant information.

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.